HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Philip P Connell Selected Research

Neoplasm Metastasis (Metastasis)

10/2022A proliferative subtype of colorectal liver metastases exhibits hypersensitivity to cytotoxic chemotherapy.
6/2012Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease.
2/2012Hypofractionated image-guided radiation therapy for patients with limited volume metastatic non-small cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Philip P Connell Research Topics

Disease

16Neoplasms (Cancer)
01/2022 - 05/2004
4Genomic Instability
01/2022 - 07/2013
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2021 - 06/2007
3Neoplasm Metastasis (Metastasis)
10/2022 - 02/2012
2Sarcoma (Soft Tissue Sarcoma)
12/2019 - 03/2010
2Residual Neoplasm
01/2019 - 08/2017
2Head and Neck Neoplasms (Head and Neck Cancer)
02/2016 - 05/2006
1Colorectal Neoplasms (Colorectal Cancer)
10/2022
1Hypersensitivity (Allergy)
10/2022
1Pathologic Complete Response
01/2022
1Triple Negative Breast Neoplasms
01/2022
1Neuroblastoma
01/2019
1Breast Neoplasms (Breast Cancer)
08/2017
1Prostatic Neoplasms (Prostate Cancer)
07/2014
1Carcinoma (Carcinomatosis)
03/2014
1Necrosis
03/2010
1Brain Neoplasms (Brain Tumor)
12/2007
1Lung Neoplasms (Lung Cancer)
06/2007
1Esophageal Neoplasms (Esophageal Cancer)
01/2007

Drug/Important Bio-Agent (IBA)

8DNA (Deoxyribonucleic Acid)IBA
10/2022 - 03/2014
4Rad51 RecombinaseIBA
11/2016 - 05/2006
3Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2013
1Biomarkers (Surrogate Marker)IBA
10/2022
1PlatinumIBA
01/2022
11,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
01/2022
1A-Form DNA (A-DNA)IBA
01/2022
1Immune Checkpoint InhibitorsIBA
10/2021
1Phosphotransferases (Kinase)IBA
01/2019
1OTS167IBA
01/2019
1AnthracyclinesIBA
08/2017
1Phenobarbital (Luminal)FDA Link
08/2017
1Nuclear Proteins (Protein, Nuclear)IBA
07/2014
1Recombinases (Recombinase)IBA
07/2013
1Carboplatin (JM8)FDA LinkGeneric
01/2007
1Pemetrexed (MTA)FDA Link
01/2007
1Hydroxyurea (Hydrea)FDA LinkGeneric
05/2006
1Paclitaxel (Taxol)FDA LinkGeneric
05/2006
1Fluorouracil (Carac)FDA LinkGeneric
05/2006
1Peptides (Polypeptides)IBA
05/2004

Therapy/Procedure

10Therapeutics
10/2022 - 05/2004
8Radiotherapy
12/2019 - 05/2006
7Drug Therapy (Chemotherapy)
10/2022 - 05/2006
2Neoadjuvant Therapy
01/2022 - 06/2007
1Immunotherapy
10/2021
1Image-Guided Radiotherapy
02/2012
1Surgical Amputation (Amputations)
03/2010
1Chemoradiotherapy
03/2010
1Induction Chemotherapy
05/2006